HomeNewsBusinessAsian shares decline, Trump tariffs spook pharma
Trending Topics

Asian shares decline, Trump tariffs spook pharma

After a $15 trillion rebound in global equities from April’s lows, traders now face a wall of uncertainty as tariff headlines return to weigh on markets.

September 26, 2025 / 06:50 IST
Story continues below Advertisement
MSCI’s equity gauge for the region fell 0.3% with South Korean stocks leading the losses.
MSCI’s equity gauge for the region fell 0.3% with South Korean stocks leading the losses.

Asian stocks retreated after concerns about lofty valuations and mixed signals from Federal Reserve officials on rate cuts stalled a record-breaking rally on Wall Street.

MSCI’s equity gauge for the region fell 0.3% with South Korean stocks leading the losses. That came after the S&P 500 dropped for a third session, the longest slide in a month. Daiichi Sankyo Co. and Takeda Pharmaceutical Co. were among the losers after President Donald Trump proposed 100% levy on branded, patented pharma products. The dollar held its gains and the yen edged lower, hovering near the 150-a-dollar level.

Story continues below Advertisement

S&P 500 futures pared earlier gains to trade little changed after Trump announced a 25% tariff on truck imports from Oct. 1.

After a $15 trillion rebound in global equities from April’s lows, traders now face a wall of uncertainty as tariff headlines return to weigh on markets. The Fed’s next policy move, a pivotal earnings season, and the threat of a US government shutdown are also weighing on sentiment. Attention now turns to Friday’s inflation report after the strong GDP data complicated the outlook for further easing after last week’s Fed rate cut.